Gary W. DeVane

1.3k total citations
16 papers, 960 citations indexed

About

Gary W. DeVane is a scholar working on Reproductive Medicine, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gary W. DeVane has authored 16 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gary W. DeVane's work include Ovarian function and disorders (11 papers), Reproductive Biology and Fertility (6 papers) and Assisted Reproductive Technology and Twin Pregnancy (5 papers). Gary W. DeVane is often cited by papers focused on Ovarian function and disorders (11 papers), Reproductive Biology and Fertility (6 papers) and Assisted Reproductive Technology and Twin Pregnancy (5 papers). Gary W. DeVane collaborates with scholars based in United States. Gary W. DeVane's co-authors include Samuel S.C. Yen, Howard L. Judd, Nancy M. Czekala, S. S. C. YEN, T.M. Siler, John C. Porter, Kurt Benirschke, Joe B. Massey, Jacques Cohen and Hilton I. Kort and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Gary W. DeVane

16 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary W. DeVane United States 14 619 435 284 146 115 16 960
Elías S. Canales Mexico 20 416 0.7× 169 0.4× 387 1.4× 85 0.6× 131 1.1× 58 886
William C. Buhi United States 19 270 0.4× 310 0.7× 214 0.8× 151 1.0× 147 1.3× 46 930
G D’Ambrogio Italy 18 488 0.8× 282 0.6× 182 0.6× 143 1.0× 118 1.0× 45 876
H. van Kessel Netherlands 16 475 0.8× 293 0.7× 478 1.7× 73 0.5× 154 1.3× 42 1.1k
Béatrice Couzinet France 21 879 1.4× 595 1.4× 585 2.1× 100 0.7× 332 2.9× 44 1.5k
Stathis Papavasiliou Greece 17 300 0.5× 206 0.5× 241 0.8× 148 1.0× 129 1.1× 31 860
D. L. Healy Australia 13 292 0.5× 256 0.6× 185 0.7× 65 0.4× 172 1.5× 21 610
B Cartwright United Kingdom 3 503 0.8× 495 1.1× 196 0.7× 125 0.9× 234 2.0× 3 1.0k
E Y Adashi United States 13 394 0.6× 400 0.9× 219 0.8× 60 0.4× 161 1.4× 17 858
S de Muinck Keizer‐Schrama Netherlands 6 500 0.8× 497 1.1× 222 0.8× 139 1.0× 277 2.4× 7 1.1k

Countries citing papers authored by Gary W. DeVane

Since Specialization
Citations

This map shows the geographic impact of Gary W. DeVane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary W. DeVane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary W. DeVane more than expected).

Fields of papers citing papers by Gary W. DeVane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary W. DeVane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary W. DeVane. The network helps show where Gary W. DeVane may publish in the future.

Co-authorship network of co-authors of Gary W. DeVane

This figure shows the co-authorship network connecting the top 25 collaborators of Gary W. DeVane. A scholar is included among the top collaborators of Gary W. DeVane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary W. DeVane. Gary W. DeVane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Baker, Valerie L., Kevin J. Doody, Russell A. Foulk, et al.. (2014). A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Human Reproduction. 29(10). 2212–2220. 53 indexed citations
3.
DeVane, Gary W., et al.. (2000). Optimal pregnancy outcome in a minimal-stimulation in vitro fertilization program. American Journal of Obstetrics and Gynecology. 183(2). 309–315. 5 indexed citations
4.
Shideler, S. E., Gary W. DeVane, Pushpa S. Kalra, Kurt Benirschke, & B. L. Lasley. (1989). Ovarian-pituitary hormone interactions during the perimenopause. Maturitas. 11(4). 331–339. 78 indexed citations
5.
Cohen, Jacques, et al.. (1988). Cryopreserved zygotes and embryos and endocrinologie factors in the replacement cycle. Fertility and Sterility. 50(1). 61–67. 43 indexed citations
6.
Cohen, Jacques, Gary W. DeVane, Carlene W. Elsner, et al.. (1988). Cryopreservation of zygotes and early cleaved human embryos. Fertility and Sterility. 49(2). 283–289. 70 indexed citations
7.
DeVane, Gary W. & David S. Guzick. (1986). Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea. Fertility and Sterility. 46(6). 1026–1031. 15 indexed citations
8.
DeVane, Gary W. & David S. Guzick. (1986). Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea.. PubMed. 46(6). 1026–31. 16 indexed citations
9.
Blackwell, Richard E., Edwin L. Bradley, Lanning B. Kline, et al.. (1983). Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study. Fertility and Sterility. 39(6). 744–748. 19 indexed citations
10.
Schedewie, H, Edward O. Reiter, Inese Z. Beitins, et al.. (1981). Testicular Leydig Cell Hyperplasia as a Cause of Familial Sexual Precocity*. The Journal of Clinical Endocrinology & Metabolism. 52(2). 271–278. 88 indexed citations
11.
DeVane, Gary W. & John C. Porter. (1980). An Apparent Stress-Induced Release of Arginine Vasopressin by Human Neonates*. The Journal of Clinical Endocrinology & Metabolism. 51(6). 1412–1416. 57 indexed citations
12.
Abu-Fadil, Salim, Gary W. DeVane, T.M. Siler, & S. S. C. YEN. (1976). Effects of oral contraceptive steroids on pituitary prolactin secretion. Contraception. 13(1). 79–85. 60 indexed citations
13.
DeVane, Gary W., Nancy M. Czekala, Howard L. Judd, & Samuel S.C. Yen. (1975). Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. American Journal of Obstetrics and Gynecology. 121(4). 496–500. 290 indexed citations
14.
Vandenberg, Grant W., Gary W. DeVane, & S. S. C. YEN. (1974). Effects of Exogenous Estrogen and Progestin on Pituitary Responsiveness to Synthetic Luteinizing Hormone-Releasing Factor. Journal of Clinical Investigation. 53(6). 1750–1754. 37 indexed citations
15.
DeVane, Gary W., T.M. Siler, & S. S. C. YEN. (1974). ACUTE SUPPRESSION OF INSULIN AND GLUCOSE LEVELS BY SYNTHETIC SOMATOSTATIN IN NORMAL HUMAN SUBJECTS1. The Journal of Clinical Endocrinology & Metabolism. 38(5). 913–915. 50 indexed citations
16.
Judd, Howard L., Kurt Benirschke, Gary W. DeVane, Stewart R. Reuter, & Samuel S.C. Yen. (1973). Maternal Virilization Developing during a Twin Pregnancy. New England Journal of Medicine. 288(3). 118–122. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026